NCT00750659
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
- Locations
-
- Chaim Sheba Medical Center Tel Litwinsky, Israel
Clinical trial condition
Leukemia, Lymphoid
Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.
3,018 public trials
549 recruiting studies
Leukemia, Lymphoid trial results
NCT01744626
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Clearview Cancer Institute Huntsville, Alabama, United States
- Horizon Oncology Research, Inc Lafayette, Indiana, United States
- Hackensack UMC Hackensack, New Jersey, United States
- The West Clinic Memphis, Tennessee, United States
NCT01075425
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Virginia Commonwealth University Richmond, Virginia, United States
Completed
A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
NCT00532129
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Birmingham, United Kingdom
- Bournemouth, United Kingdom
- Cambridge, United Kingdom
- Canterbury, United Kingdom
NCT01410513
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +19 more
- Locations
-
- Investigational Site Number 840004 Aurora, Colorado, United States
- Investigational Site Number 840006 Augusta, Georgia, United States
- Investigational Site Number 840002 Charleston, South Carolina, United States
NCT00529360
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +12 more
- Locations
-
- New York Medical College Vallhala, New York, United States
NCT00293384
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +112 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Completed
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
NCT01466881
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
- The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
NCT01461538
- Conditions
- Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Anemia, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States
- Rocky Mountain Cancer Centers - Aurora Aurora, Colorado, United States
NCT01413568
- Conditions
- Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Blood Protein Disorders, +36 more
- Locations
-
- University of Kansas Cancer Center Kansas City, Kansas, United States
- Washington University School of Medicine St Louis, Missouri, United States